Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025
Compare Balance Sheet Results of Brawn Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.00
5.91
-2.91
-49.24%
Share Warrants & Outstandings
Total Reserve
1.34
2.40
-1.06
-44.17%
Shareholder's Funds
4.34
8.31
-3.97
-47.77%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.10
-0.10
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.10
-0.10
-100.00%
Deferred Tax Assets / Liabilities
-1.45
0.00
-1.45
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
1.29
0.00
1.29
0.00%
Long Term Provisions
0.06
0.00
0.06
0.00%
Total Non-Current Liabilities
-0.11
0.10
-0.21
-210.00%
Current Liabilities
Trade Payables
14.41
0.12
14.29
11,908.33%
Other Current Liabilities
0.70
0.13
0.57
438.46%
Short Term Borrowings
0.00
0.99
-0.99
-100.00%
Short Term Provisions
0.06
0.00
0.06
0.00%
Total Current Liabilities
15.17
1.24
13.93
1,123.39%
Total Liabilities
19.40
9.65
9.75
101.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.05
1.50
-0.45
-30.00%
Less: Accumulated Depreciation
0.69
0.86
-0.17
-19.77%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.36
0.65
-0.29
-44.62%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
1.92
1.44
0.48
33.33%
Total Non-Current Assets
2.28
2.08
0.20
9.62%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
10.06
1.17
8.89
759.83%
Sundry Debtors
3.55
0.94
2.61
277.66%
Cash and Bank
0.28
0.06
0.22
366.67%
Other Current Assets
0.17
2.48
-2.31
-93.15%
Short Term Loans and Advances
3.06
2.93
0.13
4.44%
Total Current Assets
17.12
7.56
9.56
126.46%
Net Current Assets (Including Current Investments)
1.95
6.33
-4.38
-69.19%
Total Current Assets Excluding Current Investments
17.12
7.56
9.56
126.46%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
19.40
9.65
9.75
101.04%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
1.09
-1.09
-100.00%
Book Value per share (adjusted)
14.46
14.06
0.40
2.84%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -21.74% vs 39.39% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 17.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.17% vs 33.18% in Mar 2025